Pharmaceutical Technology, February 2012 Issue (PDF)
FDA and Justice Department Address Drug Quality Concerns
FDA's Social Media Insight
Expanding Capabilities in the Pharmaceutical Cold Chain
Evaluating Impurities in Drugs (Part I of III)
Reducing Common Cause Variation
Formulation Development Forum: Boronate Cross-linked Micelles
Saving the Next Generation of Regulatory Scientists
In the Spotlight February 2012
Single-Use High Capacity Membrane Chromatography
An Enhanced Approach to Drug-Substance Development and Manufacture